COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or in people with serious comorbidities. Lung destruction appears to be associated with a cytokine storm related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger of pulmonary failure. This article demonstrates the importance of IL6 in progression of disease and the possibility of inhibition of IL6 signaling in COVID-19 therapy.

BIOCEV Vestec Czech Republic

Department of Cell Biology Faculty of Sciences Charles University Prague Czech Republic

Institute of Anatomy 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. PubMed DOI PMC

Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, Tan K-S, Wang D-Y, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7:11. doi: 10.1186/s40779-020-00240-0. PubMed DOI PMC

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li Jin, Li Jia, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L. Clinical and biochemical indexes from 2019-nCoV-infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364–374. doi: 10.1007/s11427-020-1643-8. PubMed DOI PMC

Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequnces of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529–539. doi: 10.1007/s00281-017-0629-x. PubMed DOI PMC

Lau SKP, Lau CCY, Chan K-H, Li CPY, Chen H, Jin D-Y, Chan JFW, Woo PCY, Yuen K-Y. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment. J Gen Virol. 2013;94:2679–2690. doi: 10.1099/vir.0.055533-0. PubMed DOI

Mahmud-Al-Rafa A, Majumder A, Rahman KMT, Hasan AMM, Islam KMD, Taylor-Robinson AW, Billah M. Decoding the enigma of antiviral crisis: Does one target molecule regulate all. Cytokine. 2019;115:13–23. doi: 10.1016/j.cyto.2018.12.008. PubMed DOI PMC

Wang J, Wang BJ, Yang JC, Wang MY, Chen C, Luo GX, He WF. Advances in the research of mechanism of pulmonary fibrosis induced by corona Virus disease 2019 and the corresponding therapeutic measures. Zhonghua Shao Shang Za Zhi. 2020;36:E006. doi: 10.3760/cma.j.cn501120-20200307-00132. PubMed DOI

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0. PubMed DOI PMC

Pedersen SF, Ho YC. SARS-CoV-2: A storm is raging. J Clin Invest. 2020;2020:137647. doi: 10.1016/S0140-6736(20)30628-0. PubMed DOI PMC

White JP. IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm. Transl Cancer Res. 2017;6(Suppl 2):S280–S285. doi: 10.21037/tcr.2017.03.52. PubMed DOI PMC

Lacina L, Kodet O, Dvořánková B, Szabo P, Smetana K Jr. Ecology of melanoma cell. Histol Histopathol. 2018;33:247–254. doi: 10.14670/HH-11-926. PubMed DOI

Lacina L, Brábek J, Král V, Kodet O, Smetana K Jr. Interleukin-6: A molecule with complex biological impact in cancer. Histol Histopathol. 2019;34:125–136. doi: 10.14670/HH-18-033. PubMed DOI

Krüttgen A, Rose-John S. Interleukin-6 in sepsis and capillary leakage syndrome. J Interferon Cytokine Res. 2012;32:60–65. doi: 10.1089/jir.2011.0062. PubMed DOI

Simons M, Apor E, Butera JN, Treaba DO. TAFRO Syndrome associated with EBV and successful triple therapy treatment: Case report and review of the literature. Case Rep Hematol. 2016;2016:4703608. doi: 10.1155/2016/4703608. PubMed DOI PMC

Knight D, Mutsaers SE, Prêle CM. STAT3 in tissue fibrosis: Is there a role in the lung. Pulm Pharmacol Ther. 2011;24:193–198. doi: 10.1016/j.pupt.2010.10.005. PubMed DOI

Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234–248. doi: 10.1038/nrclinonc.2018.8. PubMed DOI PMC

Pappas DA, Etzel CJ, Crabtree M, Blachley T, Best J, Zlotnick S, Kremer JM. Effectiveness of Tocilizumab in patients with rheumatoid arthritis is unaffected by comorbidity burden or obesity: Data from a US registry. J Rheumatol. 2020;pii:jrheum.190282. doi: 10.3899/jrheum.190282. PubMed DOI

Plzák J, Bouček J, Bandúrová V, Kolář M, Hradilová M, Szabo P, Lacina L, Chovanec M, Smetana K Jr. The head and neck squamous cell carcinoma microenvironment as a potential target for cancer therapy. Cancers. 2019;11:440. doi: 10.3390/cancers11040440. PubMed DOI PMC

Tanaka T, Narazaki M, Kishimotoz T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. 2016;8:959–970. doi: 10.2217/imt-2016-0020. PubMed DOI

Xu X, Han M, Li T, Sun W, Wang D, Binqing Fu, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Effective treatment of severe COVID-19 patients with tocilizumab, 2020. Available at: https://www.ser.es/wp-content/uploads/2020/03/TCZ-and-COVID-19.pdf. [Last accessed on April 22, 2020] PubMed PMC

Roche pleads for global harmony as it supercharges production of Actemra, COVID-19 tests. Available at: https://www.fiercepharma.com/manufacturing/roche-pleads-for-globalharmony-as-it-supercharges-production-actemra-COVID-19-tests. [Last accessed on April 22, 2020]

Genentech announces FDA approval of clinical trial for Actemra to treat hospitalized patients with severe COVID-19 pneumonia. Available at: https://www.gene.com/media/press-releases/14843/2020-03-23/genentech-announces-fda-approval-of-clin. [Last accessed on March 23, 2020].

Wallace DJ, Linker-Israeli M, Metzger A, Stecher VJ. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE. Lupus. 1993;2(Suppl 1):S13–S15. PubMed

Kanvinde S, Singh Chhonker Y, Ahmad R, Yu F, Sleightholm R, Tang W, Jaramillo L, Chen Y, Sheinin Y, Li J, Murry DJ, Singh AB, Oupický D. Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease. Acta Biomater. 2018;82:158–170. doi: 10.1016/j.actbio.2018.10.027. PubMed DOI PMC

Zhou D, Dai SMD, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob. 2020;Chemother:dkaa114. doi: 10.1093/jac/dkaa114. PubMed DOI PMC

Costedoat-Chalumeau N, Dunogué B, Morel N, Le Guern V, Guettrot-Imbert G. Hydroxychloroquine: a multifaceted treatment in lupus. Presse Med. 2014;43:e167–e180. doi: 10.1016/j.lpm.2014.03.007. PubMed DOI

Li H, Xiao H, Lin L, Jou D, Kumari V, Lin J, Li C. Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface. J Med Chem. 2014;57:632–641. doi: 10.1021/jm401144z. PubMed DOI

Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C, Huo S, Duan J, Tao J, Zhai M, Luo P, Guo J, Tian L, Mageta L, Jou D, Zhang C, Li C, Lin J, Lv J, Li S, Lin L. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. Cancer Sci. 2019;110:950–961. doi: 10.1111/cas.13940. PubMed DOI PMC

Andersson A, Bernardi AI, Stubelius A, Nurkkala-Karlsson M, Ohlsson C, Carlsten H, Islander U. Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis. Rheumatology. 2016;55:553–563. doi: 10.1093/rheumatology/kev355. PubMed DOI PMC

Yadav A, Kumar B, Teknos TN, Kumar P. Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer. Oncotarget. 2016;8:66912–66924. doi: 10.18632/oncotarget.11464. PubMed DOI PMC

Burkhardt C, Bühler L, Tihy M, Morel P, Forni M. Bazedoxifene as a novel strategy for treatment of pancreatic and gastric adenocarcinoma. Oncotarget. 2019;10:3198–3202. PubMed PMC

Thilakasiri P, Huynh J, Poh AR, Tan W, Nero TL, Tran K, Parslow AC, Afshar-Sterle S, Baloyan D, Hannan NJ, Buchert M, Scott AM, Griffin MD, Hollande F, Parker MW, Putoczki TL, Ernst M, Chand AL. Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth. EMBO Mol Med. 2019;11:e9539. doi: 10.15252/emmm.201809539. PubMed DOI PMC

Wei J, Ma L, Lai YH, Zhang R, Li H, Li C, Lin J. Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy. J Exp Clin Cancer Res. 2019;38:63. doi: 10.1186/s13046-019-1072-8. PubMed DOI PMC

Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, Shum D, Kim S. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. BioRxiv. 2020 doi: 10.1101/2020.03.20.9997301. PubMed DOI PMC

Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M, Chen T, Song S, Ma Z, Chen X, Zheng R, Cao Q, Wang F, Zhang Y. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan. China Clin Infect Dis Mar. 2020;pii:ciaa270. doi: 10.1093/cid/ciaa270. PubMed DOI PMC

Wenham C, Smithc J, Morgan R. COVID-19: the gendered impacts of the outbreak. LANCET. 2020;395:846–848. doi: 10.1016/S0140-6736(20)30526-2. PubMed DOI PMC

Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation

IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives

Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences

Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality

Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19